Dual PI3K/mTOR inhibitor NVP-BEZ235 in combination with AKT inhibitor MK2206 in esophageal carcinoma cells

被引：0
|
作者：
Yu, Hao [1 ]
Shi, Ni [1 ]
Pan, Zui [1 ]
Chen, Tong [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1253
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1253
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The combination of gemcitabine with the dual PI3K/mTOR-inhibitor NVP-BEZ235 in human pancreatic cancer cell lines
    Glienke, W.
    Hausmann, E.
    Wicht, J.
    Maute, L.
    Bergmann, L.
    ONKOLOGIE, 2011, 34 : 57 - 58
  • [22] Drug irradiation schedule is decisive for radiosensitization by the novel dual PI3K and mTOR inhibitor NVP-BEZ235
    Kuger, S.
    Graus, D.
    Brendtke, R.
    Lutyj, P.
    Soukhoroukov, V
    Flentje, M.
    Djuzenova, C. S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 67 - 67
  • [23] Dual inhibitor of PI3K and mTOR (NVP-BEZ235) augments the efficacy of fluorouracil on gastric cancer chemotherapy
    Li, Liangqing
    Zhang, Shengwei
    Xie, Diya
    Chen, Hui
    Zheng, Xuelan
    Pan, Dun
    ONCOTARGETS AND THERAPY, 2018, 11 : 6111 - 6118
  • [24] Dual PI3K/mTOR Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer
    Yasumizu, Yota
    Miyajima, Akira
    Kosaka, Takeo
    Miyazaki, Yasumasa
    Kikuchi, Eiji
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2014, 191 (01): : 227 - 234
  • [25] NVP-BEZ235, A Dual PI3K/mTOR Inhibitor, Enhances Chemotherapy and Antiangiogenic Response in Pancreatic Cancer
    Ostapoff, K. T.
    Awasthi, N.
    Yen, P. L.
    Zhang, C.
    Schwarz, M. A.
    Brekken, R. A.
    Schwarz, R. A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S46 - S46
  • [26] Effect of the combination of the dual mTOR/pI3K inhibitor NVP-BEZ235 with gemcitabine on growth inhibition in pancreatic cancer cells in vitro and in vivo
    Maute, Luise
    Wicht, Johannes
    Zoernig, Martin
    Niederhagen, Manuel
    Bergmann, Lothar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells
    Moon, Du G.
    Lee, Sang E.
    Oh, Mi M.
    Lee, Sang C.
    Jeong, Seong J.
    Hong, Sung K.
    Yoon, Cheol Y.
    Byun, Seok S.
    Park, Hong S.
    Cheon, Jun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 1027 - 1035
  • [28] NVP-BEZ235, A DUAL PI3K/MTOR INHIBITOR SYNERGISTICALLY POTENTIATES ANTITUMOR EFFECT OF CISPLATIN IN BLADDER CANCER CELLS
    Park, Hong Seok
    Yoon, Cheol Yong
    Cheon, Jun
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A206 - A206
  • [29] NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
    Wen-juan Wang
    Lin-mei Long
    Neng Yang
    Qing-qing Zhang
    Wen-jun Ji
    Jiang-hu Zhao
    Zheng-hong Qin
    Zhong Wang
    Gang Chen
    Zhong-qin Liang
    Acta Pharmacologica Sinica, 2013, 34 : 681 - 690
  • [30] NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
    Wang, Wen-juan
    Long, Lin-mei
    Yang, Neng
    Zhang, Qing-qing
    Ji, Wen-jun
    Zhao, Jiang-hu
    Qin, Zheng-hong
    Wang, Zhong
    Chen, Gang
    Liang, Zhong-qin
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (05) : 681 - 690
12345